Acne severity sits at the center of this dementia and brain health question.

Acne severity grades are standardized measurements that dermatologists use to classify how serious your acne is and guide treatment decisions. Rather than simply saying you have “bad acne,” these grading systems provide a clear numerical or categorical framework—so when your dermatologist tells you that you have Grade II or moderate acne with a GAGS score of 24, that information tells a precise story about your condition. Understanding what your specific grade means helps you know what treatment options make sense, how aggressive the therapy needs to be, and what results you can realistically expect over time.

This article explains the most commonly used acne classification systems, from the straightforward four-grade scale that many dermatologists reference to the more detailed Global Acne Grading System (GAGS) that provides a numerical score. You’ll learn what distinguishes mild acne from severe acne, how dermatologists arrive at these grades, and—critically—what your grade actually means for your treatment plan. We’ll also cover the fact that more than 25 different grading systems exist worldwide, which newer AI tools are helping to standardize, and what that means for consistency in your care.

The Four-Grade Classification System—The Foundation of Acne Diagnosis
The Global Acne Grading System (GAGS)—The Clinical Standard
Alternative Grading Systems—Hayashi Criteria and Beyond
What Each Severity Grade Means for Your Treatment Options
The Subjectivity Problem and Challenges in Grading
Artificial Intelligence and Standardized Acne Grading
What Your Diagnosis Means—Moving Forward with Understanding
Conclusion

The Four-Grade Classification System—The Foundation of Acne Diagnosis

The most straightforward way dermatologists classify acne divides it into four grades based on the types and distribution of lesions on the face. Grade I acne consists primarily of open comedones (blackheads) scattered across the face, with few if any inflamed lesions. Grade II introduces closed comedones (whiteheads) and increases the total number of comedones overall. Grade III is where papules and pustules—the red, raised, sometimes painful lesions—become more prominent, appearing alongside the comedones.

Grade IV represents the most severe form, combining all the previous elements: multiple open and closed comedones, numerous papules and pustules, plus the addition of cysts, which are deeper, larger lesions that often leave scars. This system is intuitive because it directly reflects what you see when you look in the mirror—if your face has mostly blackheads and whiteheads with very few red bumps, you’re likely Grade I or II. If you see a mix of red bumps, some larger nodules, and extensive comedone coverage, you’re probably Grade III or IV. The key limitation of this four-grade system, however, is that it doesn’t account for the *location* of lesions or their *distribution* across different areas of the face, which matters because acne on the cheeks behaves differently than acne on the forehead or chest. This is why dermatologists often turn to more detailed scoring systems for treatment planning.

The Four-Grade Classification System—The Foundation of Acne Diagnosis

The Global Acne Grading System (GAGS)—The Clinical Standard

The Global Acne Grading System (GAGS) is the most widely used acne severity assessment tool in clinical dermatology because it accounts for both the type of lesion *and* where it appears on the face. Dermatologists assess six facial zones (forehead, right cheek, left cheek, nose, chin, and chest/back) separately, scoring each zone from 0 to 4 based on the severity and density of lesions in that area. The total score across all zones determines the overall severity: a score of 1–18 indicates mild acne, 19–30 indicates moderate acne, 31–38 indicates severe acne, and a score greater than 39 indicates very severe acne.

The advantage of GAGS is precision—it tells you not just that you have acne, but exactly where the worst areas are and how concentrated the problem is. For example, someone might have a GAGS score of 22 (moderate) because they have significant forehead acne but clear cheeks, while another person with the same score of 22 might have widespread but lighter acne across multiple zones. This distinction matters because treatment strategies differ: concentrated forehead acne might respond well to a targeted topical medication, whereas distributed acne often requires systemic therapy. However, GAGS requires a trained examiner to score accurately, and there’s still some subjective judgment involved in determining whether a lesion rates a “2” versus a “3” on any given zone, which can introduce variation between different clinicians.

Alternative Grading Systems—Hayashi Criteria and Beyond

Beyond GAGS, dermatologists in different regions use other classification systems. The Hayashi Criteria, commonly used in Asia and referenced in the Indian Journal of Dermatology, classifies acne based purely on the count of inflammatory eruptions on half of the face: mild acne has 0–5 eruptions, moderate has 6–20, severe has 21–50, and very severe has more than 50. This system is straightforward and doesn’t require dividing the face into zones, making it quick to apply during a busy clinic visit. For a patient with a few red bumps scattered on one side of their face, the Hayashi system immediately identifies them as mild, whereas someone with dozens of papules and pustules would clearly fall into the severe category.

The medical literature documents more than 25 different acne grading systems worldwide, including the Leeds Revised Acne Grading System, which uses 12 grades specifically for facial acne and 8 grades for acne on the upper chest and back. This proliferation of systems reflects the fact that there’s no single perfect way to measure acne—each system emphasizes different aspects (lesion count, lesion type, distribution, scarring risk) depending on what clinicians in that region or specialty found most useful. The downside is that this multiplicity makes it difficult to compare research studies or patient outcomes across different countries or healthcare systems, since an acne grade of “moderate” in one country might be defined differently in another. Efforts are ongoing to standardize these systems globally.

Alternative Grading Systems—Hayashi Criteria and Beyond

What Each Severity Grade Means for Your Treatment Options

Your acne grade directly determines which treatments your dermatologist will recommend. Mild acne (whether Grade I or GAGS 1–18) is typically treated with topical medications alone: benzoyl peroxide cleansers, salicylic acid exfoliants, retinoids like adapalene, or topical antibiotics. These work on the surface and in the upper layers of the skin. Moderate acne (Grade II–III or GAGS 19–30) usually requires combination therapy, such as a topical retinoid plus an oral antibiotic or, for those who can take it, hormonal contraceptives in females.

At this level, the dermatologist recognizes that surface treatments alone won’t sufficiently control the inflammation and lesion formation. Severe and very severe acne (Grade IV or GAGS 31+) is a different animal entirely and often warrants treatment with isotretinoin (Accutane), the strongest acne medication available. This oral medication fundamentally changes how your skin produces oil and can clear acne for months or years, but it requires monthly blood tests and pregnancy tests (if applicable) and carries teratogenic risks. The key practical point: your grade isn’t just a label—it’s the threshold that determines whether your dermatologist will pursue aggressive intervention. Someone with GAGS score of 28 (moderate) might reasonably try oral antibiotics for three months before escalating, while someone with GAGS score of 35 (severe) might move more quickly toward stronger options because the scarring risk is higher and faster clearance is needed to prevent permanent marks.

The Subjectivity Problem and Challenges in Grading

One significant limitation in acne grading is that even standardized systems require human judgment, and different dermatologists may score the same patient differently. Two experienced clinicians might examine the same face and assign GAGS scores of 24 and 26—technically “moderate” in both cases, but a difference that could influence treatment intensity. This subjectivity becomes especially problematic in clinical trials for new acne medications, where inconsistent grading can skew results, and in insurance coverage decisions, where whether a patient’s acne qualifies as “severe” enough for isotretinoin can be the difference between approval and denial. Photography and standardized lighting help reduce this variability, but they don’t eliminate it entirely.

Additionally, acne is dynamic—your severity grade can change week to week depending on hormone fluctuations, stress, skincare, and medication adherence. A patient graded as moderate at one appointment might be mild at the next, or conversely, might flare into severe territory. This means your grade is a snapshot in time, not a permanent diagnosis. Some patients and clinicians find this frustrating, but it also means that if you’re making progress with your current treatment, your grade will improve, which is often motivation enough to stay compliant.

The Subjectivity Problem and Challenges in Grading

Artificial Intelligence and Standardized Acne Grading

Recent advances in medical technology are addressing the subjectivity problem. A deep learning AI model trained on acne lesion detection achieved 90% accuracy in classifying acne severity using facial photographs compared to the traditional Investigator’s Global Assessment (IGA) scale, a four-point scale (0–4) that dermatologists have used for decades. These AI-based systems analyze lesion characteristics, distribution, and severity from images without the human bias that can creep into manual assessment.

Several institutions and companies are now integrating these tools into clinical workflows, allowing patients to photograph their face at home and receive an objective severity score within minutes. While AI grading systems show promise for reducing subjectivity and making acne assessment more consistent across different clinicians and geographic regions, they’re not yet standard in most dermatology offices. The technology is advancing rapidly as of 2024–2025, and over time these tools may become as routine as blood pressure measurement. The practical implication for you as a patient is that if you’re enrolled in a clinical trial or using a teledermatology platform, you might encounter an AI-assisted severity assessment, and that’s an indication that your care is being measured with state-of-the-art objectivity.

What Your Diagnosis Means—Moving Forward with Understanding

When your dermatologist tells you your acne grade, they’re translating a visual assessment into a language that predicts treatment response and scarring risk. A patient told they have Grade I acne can reasonably expect that a three-month course of topical retinoid and benzoyl peroxide will produce noticeable improvement without needing systemic medication. Conversely, someone with GAGS score of 40 (very severe) should understand that their acne carries a significant risk of permanent scarring if untreated and that aggressive intervention is justified, even if it means tolerating the side effects of isotretinoin.

The future of acne grading likely involves hybrid systems that combine clinical examination with AI analysis, mobile apps that track your severity over time, and standardization across international dermatology societies. For now, the best approach is to understand your specific grade, ask your dermatologist what that grade means for your treatment plan and timeline, and keep communication open about whether your current therapy is working. Your grade isn’t a judgment; it’s a tool to guide the right treatment for you.

Conclusion

Acne severity grades are standardized measures that dermatologists use to classify how serious your acne is and determine the best treatment approach. The most common system divides acne into four grades based on lesion types, while the Global Acne Grading System (GAGS) provides a numerical score (1–4 scale for each facial zone) that accounts for both lesion severity and distribution. Alternative systems like the Hayashi Criteria exist worldwide, and more than 25 different grading systems are documented in medical literature, though standardization efforts are ongoing to improve consistency across regions and clinicians.

Understanding what your grade means empowers you to have informed conversations with your dermatologist about what to expect from treatment, when escalation to stronger medications might be necessary, and when to seek a second opinion if your acne isn’t responding as predicted. As AI and digital assessment tools become more integrated into dermatology, acne grading will likely become even more objective and accessible, potentially allowing patients to track their own severity at home. For now, your grade is the bridge between what you see in the mirror and the medical plan that will help clear your skin.